American Portfolios Advisors’s 10x Genomics TXG Stock Holding History

American Portfolios Advisors’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$120K	Buy	4,206 +19	+0.5%	+$724	0.01%	1252
2022 Q2	$189K	Sell	4,187 -71	-2%	-$3.68K	0.01%	1068
2022 Q1	$324K	Buy	4,258 +61	+1%	+$5.34K	0.01%	938
2021 Q4	$625K	Buy	4,197 +280	+7%	+$42.9K	0.02%	645
2021 Q3	$570K	Buy	3,917 +198	+5%	+$34K	0.02%	651
2021 Q2	$728K	Buy	3,719 +998	+37%	+$181K	0.03%	564
2021 Q1	$493K	Sell	2,721 -961	-26%	-$166K	0.02%	659
2020 Q4	$521K	Buy	3,682 +3,656	+14,062%	+$531K	0.03%	548
2020 Q3	$3.24K	Buy	+26	New	+$2.73K	﹤0.01%	2439

Other funds holding TXG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

SIM

SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

American Portfolios Advisors's TXG Position: Q3 2022 in Review

American Portfolios Advisors increased its 10x Genomics (TXG) stake by 0.45% in Q3 2022, buying an estimated $724 and bringing the position to 4,206 shares worth $120K. The position accounts for 0.01% of the portfolio, ranked #1252.

American Portfolios Advisors first reported a position in TXG in Q3 2020 and has held it in 9 quarters since. The position peaked at $728K in Q2 2021. 233 funds tracked by Wall St. Rank hold TXG as of Q3 2022.

American Portfolios Advisors held 4,206 shares of 10x Genomics worth $120K as of Q3 2022.
American Portfolios Advisors bought 19 10x Genomics shares in Q3 2022, an estimated $724.
10x Genomics made up 0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #1252 holding.
American Portfolios Advisors first reported a position in 10x Genomics in Q3 2020 and has held it in 9 quarters since.
American Portfolios Advisors's 10x Genomics position peaked at $728K in Q2 2021.
233 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.